CapCof (Capital Pharmaceutical, LLC)


Welcome to the PulseAid listing for the CapCof drug offered from Capital Pharmaceutical, LLC. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Capital Pharmaceutical, LLC
NON-PROPRIETARY NAME: Codeine Phosphate, Phenylephrine Hydrochloride, Chlorpheniramine Maleate
SUBSTANCE NAME: CODEINE PHOSPHATE; PHENYLEPHRINE HYDROCHLORIDE; CHLORPHENIRAMINE MALEATE
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: LIQUID
MARKETING CATEGORY NAME: OTC MONOGRAPH FINAL
START MARKETING DATE: 2010-10-08
END MARKETING DATE: 0000-00-00


CapCof HUMAN OTC DRUG Details:

Item DescriptionCapCof from Capital Pharmaceutical, LLC
LABELER NAME: Capital Pharmaceutical, LLC
DEA SCHEDULE: CV
ACTIVE STRENGTH: 10; 5; 2(mg/5mL; mg/5mL; mg/5mL)
START MARKETING DATE: 2010-10-08
END MARKETING DATE: 0000-00-00
PRODUCT ID: 29978-420_d73cec86-e710-4d93-b81b-28d10707164b
PRODUCT NDC: 29978-420
APPLICATION NUMBER: part341

Other CODEINE PHOSPHATE; PHENYLEPHRINE HYDROCHLORIDE; CHLORPHENIRAMINE MALEATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Capital Pharmaceutical, LLCCapCof